在阿尔多斯特的生产和作用中的微RNAs
Scott M MacKenzie1, Lara A Birch1, Stelios Lamprou1
1School of Cardiovascular and Metabolic Health, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Vitamins and hormones
|February 26, 2024
概括
微RNAs影响阿尔多斯激素水平,影响血压调节. 循环中的microRNAs可以作为生物标志物来诊断原发性阿尔多斯特隆症,这是一种常见且可治疗的高血压形式.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 阿尔多斯特调节血压,由上腺分泌,受氨酸-血管新生素系统和下丘脑-垂体-上腺轴的影响.
- 微RNA是非编码RNA,可以在转录后调节基因表达.
- 在阿尔多激素失调条件下观察到异常的microRNA水平.
研究的目的:
- 总结当前关于微RNAs在阿尔多斯特生产和作用中的作用的研究.
- 探索循环中的microRNAs作为初级阿尔多斯特主义的诊断生物标志物的潜力.
主要方法:
- 对调查微RNA参与阿尔多路径的研究进行文献综述.
- 对与阿尔多斯特相关疾病中的微RNA失调研究的分析.
- 讨论初级阿尔多斯特龙症中循环的microRNA的诊断潜力.
主要成果:
- 已经确定了微RNAs来调节参与阿尔多的合成和信号传递的基因.
- 微RNA表达的变化与阿尔多斯特失调有关.
- 循环中的microRNAs显示出作为原发性阿尔多斯特隆主义的潜在生物标志物具有前途.
结论:
- 微RNA在复杂的阿尔多斯特调节中起着重要作用.
- 循环中的microRNAs代表了早期和准确诊断原发性阿尔多斯特主义的有希望的途径,这是一个可治疗的疾病.
- 需要进一步的研究来验证microRNAs作为高血压管理的可靠诊断生物标志物.
相关概念视频
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
01:26Regulation of Sodium and Potassium
534
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
534
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
554
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
554
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638